CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $3.59B, above the global median of $1.15B
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.72%Below 5Y avg (1.33%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
57.1%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
24.21BCNY3.59B · vs all stocks (USD)
Trailing P/E
81.40xRevenue (TTM)
2.51BCNY372.64M · vs all stocks (USD)
Profit Margin
11.66%Beta
0.6100xvs all stocks
52-Week Change
21.59%vs all stocks
Market Capitalization
24.21BCNY3.59B · vs all stocks (USD)
Enterprise Value
23.09BCNY3.42B · vs all stocks (USD)
Trailing P/E
81.40xForward P/E
66.26xPrice to Sales (TTM)
9.64xPrice to Book (MRQ)
5.82xEnterprise to Revenue
9.19xEnterprise to EBITDA
54.63xGross Margin
57.29%Profit Margin
11.66%Operating Margin
18.75%Return on Assets (TTM)
3.65%Return on Equity (TTM)
6.79%Revenue (TTM)
2.51BCNY372.64M · vs all stocks (USD)
Revenue per Share (TTM)
3.00CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-1.60%Gross Profit (TTM)
1.41BCNY209.03M · vs all stocks (USD)
EBITDA (TTM)
408.35MCNY60.56M · vs all stocks (USD)
Net Income (TTM)
292.97MCNY43.45M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
20.80%Operating Cash Flow (TTM)
475.35MCNY70.50M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-29.63MCNY-4.39M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2000CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.72%vs all stocks
5-Year Average Dividend Yield
1.33%vs all stocks
Payout Ratio
57.14%Minority Interest (Equity)
91.68MCNYFY2025 · Dec 31, 2025Revenue
2.52BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.11BCNYFY2025 · Dec 31, 2025Gross Profit
1.42BCNYFY2025 · Dec 31, 2025Operating Income
320.61MCNY47.55M · vs all stocks (USD)
Pre-tax Income
296.59MCNYFY2025 · Dec 31, 2025Income Tax Expense
29.88MCNYFY2025 · Dec 31, 2025Net Income
266.70MCNYFY2025 · Dec 31, 2025EBIT
301.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
472.50MCNYFY2025 · Dec 31, 2025Research & Development
91.03MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
851.13MCNYFY2025 · Dec 31, 2025Other Operating Expenses
20.26MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.86MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.00MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
835.62MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
835.62MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
266.70MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
9.05MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
139.63MCNYFY2025 · Dec 31, 2025Free Cash Flow
-168.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
977.89MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
266.70MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.34MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-214.10MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
83.68MCNYFY2025 · Dec 31, 2025Capital Expenditures
-307.97MCNYFY2025 · Dec 31, 2025Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025Purchase of Investments
-945.00MCNYFY2025 · Dec 31, 2025Sale of Investments
1.30BCNYFY2025 · Dec 31, 2025Other Investing Activity
79.00CNYFY2025 · Dec 31, 2025Net Investing Cash Flow
46.16MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
327.95MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-304.29MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-170.31MCNYFY2025 · Dec 31, 2025Other Financing Charges
-588.88MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-735.53MCNYFY2025 · Dec 31, 2025Shares Outstanding
849.93MSharesUpdated Aug 19, 2026Float Shares
732.93MSharesUpdated Aug 19, 2026% Held by Insiders
28.23%vs all stocks
% Held by Institutions
5.27%vs all stocks
Total Cash (MRQ)
1.51BCNY223.20M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.77CNYUpdated Aug 19, 2026Total Debt (MRQ)
295.30MCNY43.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0695xCurrent Ratio (MRQ)
4.13xBook Value per Share (MRQ)
4.89CNYUpdated Aug 19, 2026Total Assets
5.13BCNY760.71M · vs all stocks (USD)
Total Current Assets
3.04BCNYFY2025 · Dec 31, 2025Total Liabilities
979.71MCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.09BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
261.39MCNYFY2025 · Dec 31, 2025Total Current Liabilities
718.32MCNYFY2025 · Dec 31, 2025Cash
977.89MCNYFY2025 · Dec 31, 2025Cash Equivalents
7.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
985.40MCNYFY2025 · Dec 31, 2025Other Short-term Investments
103.66MCNYFY2025 · Dec 31, 2025Accounts Receivable
572.74MCNYFY2025 · Dec 31, 2025Inventory
365.30MCNYFY2025 · Dec 31, 2025Accounts Payable
117.96MCNYFY2025 · Dec 31, 2025Short-term Debt
320.26MCNYFY2025 · Dec 31, 2025Other Current Liabilities
16.90MCNYFY2025 · Dec 31, 2025Long-term Debt
6.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
849.93MCNYFY2025 · Dec 31, 2025Retained Earnings
990.32MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.15BCNY615.42M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
16.20CNYUpdated Aug 19, 202652-Week High
34.27CNYUpdated Aug 19, 202652-Week Change
21.59%vs all stocks
Beta
0.6100xvs all stocks
50-Day MA
26.19CNYUpdated Aug 19, 2026200-Day MA
21.87CNYUpdated Aug 19, 2026Avg 10-Day Volume
46.12MSharesUpdated Aug 19, 2026Avg 30-Day Volume
53.30MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.3500CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $3.59B, above the global median of $1.15BNotable
Market cap (USD): 3,591,013,210.559Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Laboratorios Farmacéuticos Rovi SA
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arcutis Biotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hualan Biological Engineering Inc.
Tier 1ProductionApproval-Gated PipelineRule
Organon & Co.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Irhythm Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Haemonetics Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pegbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Grand Pharmaceutical and Healthcare Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Ambu A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Denali Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule